Literature DB >> 7741744

Whole mitochondrial genome amplification reveals basal level multiple deletions in mtDNA of patients with dilated cardiomyopathy.

Y Y Li1, C Hengstenberg, B Maisch.   

Abstract

Basal level multiple deletions in the heart mitochondrial (mt) DNA of patients with dilated cardiomyopathy were analyzed with the recently developed long PCR technique. The amplification of the whole mitochondrial genome and the length dependent preferential amplification ensure that all existing deletions are detected simultaneously. Primer shift long PCR proved the specificity of our method in the detection of deletions. We used primers that were 15644 bp and 13765 bp apart, which comprised almost the entire mitochondrial genome, detected a total of 14 kinds of deletions in 18 out of the 40 endomyocardial biopsy samples from patients with dilated cardiomyopathy. These deletions ranged in size from 3.3 kb to 12.6 kb. The proportion of the deleted to wild-type mtDNA was calculated to be less than 9% for any of these deletions. Aged patients had a comparatively higher proportion. Deletions were rarely found in mtDNA of leukocytes from the same group of patients and of 38 additional patients, as well as in myocardia of 25 normal controls (P < 0.01). No deletion was found in leukocytic mtDNA of the 21 control subjects. It is therefore concluded that cardiomyopathic heart has a high frequency of mtDNA deletions. With regard to the low quantity and the cumulative nature of these deletions by aging, they could have only little pathogenic effect on the development of dilated cardiomyopathy, but rather be a sign of increasing stress of the heart promoting the damage of mtDNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7741744     DOI: 10.1006/bbrc.1995.1648

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1.

Authors:  C Hardy; F Khanim; R Torres; M Scott-Brown; A Seller; J Poulton; D Collier; J Kirk; M Polymeropoulos; F Latif; T Barrett
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  [Classification of cardiomyopathies according to the WHO/ISFC Task Force--more questions than answers?].

Authors:  B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

Review 3.  Electron transport chain defects in heart failure.

Authors:  Jordi Casademont; Oscar Miró
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

4.  OMA1 mediates local and global stress responses against protein misfolding in CHCHD10 mitochondrial myopathy.

Authors:  Mario K Shammas; Xiaoping Huang; Beverly P Wu; Evelyn Fessler; Insung Y Song; Nicholas P Randolph; Yan Li; Christopher Ke Bleck; Danielle A Springer; Carl Fratter; Ines A Barbosa; Andrew F Powers; Pedro M Quirós; Carlos Lopez-Otin; Lucas T Jae; Joanna Poulton; Derek P Narendra
Journal:  J Clin Invest       Date:  2022-07-15       Impact factor: 19.456

5.  Clinical, biochemical, cellular and molecular characterization of mitochondrial DNA depletion syndrome due to novel mutations in the MPV17 gene.

Authors:  Johanna Uusimaa; Julie Evans; Conrad Smith; Anna Butterworth; Kate Craig; Neil Ashley; Chunyan Liao; Janet Carver; Alan Diot; Lorna Macleod; Iain Hargreaves; Abdulrahman Al-Hussaini; Eissa Faqeih; Ali Asery; Mohammed Al Balwi; Wafaa Eyaid; Areej Al-Sunaid; Deirdre Kelly; Indra van Mourik; Sarah Ball; Joanna Jarvis; Arundhati Mulay; Nedim Hadzic; Marianne Samyn; Alastair Baker; Shamima Rahman; Helen Stewart; Andrew Am Morris; Anneke Seller; Carl Fratter; Robert W Taylor; Joanna Poulton
Journal:  Eur J Hum Genet       Date:  2013-05-29       Impact factor: 4.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.